Showing results (11-20 of 1,186) with videos related to
Sort By:
Pageof 119
Atherosclerosis|January 23, 2016
Effects of a beverage rich in (poly)phenols on established and novel risk markers for vascular disease in medically uncomplicated overweight or obese subjects: A four week randomized placebo-controlled trialAdam Mullan, Christian Delles, William Ferrell, et al.Clinical Science (London, England : 1979)|July 30, 2008
Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerationsDavid Preiss, Naveed SattarCurrent Opinion in Lipidology|June 11, 2009
Triglycerides and coronary heart disease: have recent insights yielded conclusive answers?Nadeem Sarwar, Naveed SattarCurrent Opinion in Lipidology|September 8, 2011
Statins and the risk of new-onset diabetes: a review of recent evidenceDavid Preiss, Naveed SattarThe Journal of Investigative Dermatology|September 25, 2021
Estimating Cardiovascular Impacts of Drugs for Psoriatic Disease: A Long Way to GoStefan Siebert, Naveed SattarCurrent Cardiology Reports|November 24, 2019
Management of Lipid Abnormalities in Patients with DiabetesAnne Sillars, Naveed SattarHeart (British Cardiac Society)|November 16, 2007
Metabolic syndrome, dysglycaemia and vascular disease: making sense of the evidenceDavid Preiss, Naveed SattarCurrent Obesity Reports|August 10, 2021
Obesity as a Risk Factor for Severe COVID-19: Summary of the Best Evidence and Implications for Health CareNaveed Sattar, Jonathan ValabhjiClinical Endocrinology|December 11, 2008
Lipids, lipid modifying agents and cardiovascular risk: a review of the evidenceDavid Preiss, Naveed SattarPageof 119